1	Mujer	mujer	NCFS000	C0043210#C0015780#C0086418	persona#hallazgo#estructura_corporal#organismo_vivo	0-5	469_QUEST_clinical_caseMIR	SENT1	-	-
2	de	de	SPS00	C0332285	atributo	6-8	469_QUEST_clinical_caseMIR	SENT1	-	-
3	30	30		-	-	9-11	469_QUEST_clinical_caseMIR	SENT1	-	-
4	años	año	NCMP000	C0439234	calificador	12-16	469_QUEST_clinical_caseMIR	SENT1	-	-
5	de	de	SPS00	C0001779_1	entidad_observable_1	17-19	469_QUEST_clinical_caseMIR	SENT1	-	-
6	edad	edad	NCFS000	C0001779_2	entidad_observable_2	20-24	469_QUEST_clinical_caseMIR	SENT1	-	-
7	,	,	Fc	-	-	24-25	469_QUEST_clinical_caseMIR	SENT1	-	-
8	embarazada	embarazar	VMP00SF	-	-	26-36	469_QUEST_clinical_caseMIR	SENT1	-	-
9	de	de	SPS00	C0332285	atributo	37-39	469_QUEST_clinical_caseMIR	SENT1	-	-
10	33	33		-	-	40-42	469_QUEST_clinical_caseMIR	SENT1	-	-
11	semanas	semana	NCFP000	C0439230	calificador	43-50	469_QUEST_clinical_caseMIR	SENT1	-	-
12	,	,	Fc	-	-	50-51	469_QUEST_clinical_caseMIR	SENT1	-	-
13	que	que	PR0CN000	-	-	52-55	469_QUEST_clinical_caseMIR	SENT1	-	-
14	consulta	consultar	VMM02S0	C1704447_1	calificador_1	56-64	469_QUEST_clinical_caseMIR	SENT1	-	-
15	por	por	SPS00	C1704447_2	calificador_2	65-68	469_QUEST_clinical_caseMIR	SENT1	-	-
16	prurito	prurito	NCMS000	C0036262#C0033774_1	trastorno#hallazgo_1	69-76	469_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
17	de	de	SPS00	C0332285	atributo	77-79	469_QUEST_clinical_caseMIR	SENT1	-	-
18	una	una		C0205447_1	calificador_1	80-83	469_QUEST_clinical_caseMIR	SENT1	-	-
19	semana	semana	NCFS000	C0439230	calificador	84-90	469_QUEST_clinical_caseMIR	SENT1	-	-
20	de	de	SPS00	C0332285	atributo	91-93	469_QUEST_clinical_caseMIR	SENT1	-	-
21	evolución	evolución	NCFS000	-	-	94-103	469_QUEST_clinical_caseMIR	SENT1	-	-
22	.	.	Fp	-	-	103-104	469_QUEST_clinical_caseMIR	SENT1	-	-

1	Las	el	DA0FP0	-	-	105-108	469_QUEST_clinical_caseMIR	SENT2	-	-
2	pruebas	prueba	NCFP000	-	-	109-116	469_QUEST_clinical_caseMIR	SENT2	-	-
3	hepáticas	hepático	AQ0FP0	-	-	117-126	469_QUEST_clinical_caseMIR	SENT2	B-Estructura_Corporal	-
4	muestran	mostrar	VMIP3P0	-	-	127-135	469_QUEST_clinical_caseMIR	SENT2	-	-
5	un	un		C0205447_1	calificador_1	136-138	469_QUEST_clinical_caseMIR	SENT2	-	-
6	leve	leve	AQ0CS0	C2945599#C0547040#C1282907	calificador	139-143	469_QUEST_clinical_caseMIR	SENT2	-	-
7	incremento	incremento	NCMS000	-	-	144-154	469_QUEST_clinical_caseMIR	SENT2	-	-
8	en	en	SPS00	C1720294#C0332285	calificador#atributo	155-157	469_QUEST_clinical_caseMIR	SENT2	-	-
9	los	el	DA0MP0	-	-	158-161	469_QUEST_clinical_caseMIR	SENT2	-	-
10	valores	valor	NCMP000	C0475208	calificador	162-169	469_QUEST_clinical_caseMIR	SENT2	-	-
11	de	de	SPS00	C0332285	atributo	170-172	469_QUEST_clinical_caseMIR	SENT2	-	-
12	transaminasas	transaminasa	NCFP000	C1152208#C0002594	función_biológica#sustancia	173-186	469_QUEST_clinical_caseMIR	SENT2	-	-
13	(	(	Fpa	-	-	187-188	469_QUEST_clinical_caseMIR	SENT2	-	-
14	AST	aspartato_transaminasa	NC00YL0	-	-	188-191	469_QUEST_clinical_caseMIR	SENT2	-	-
15	77	77		-	-	192-194	469_QUEST_clinical_caseMIR	SENT2	-	-
16	UI	ui	NC00SC0	C0439453	calificador	195-197	469_QUEST_clinical_caseMIR	SENT2	-	-
17	/	/	Fh	-	-	197-198	469_QUEST_clinical_caseMIR	SENT2	-	-
18	L	l	NCFS000	-	-	198-199	469_QUEST_clinical_caseMIR	SENT2	-	-
19	y	y	CC	C1706368	calificador	200-201	469_QUEST_clinical_caseMIR	SENT2	-	-
20	ALT	alanina_aminotransferasa_(o_tgp)	NC00YL0	-	-	202-205	469_QUEST_clinical_caseMIR	SENT2	-	-
21	84	84		-	-	206-208	469_QUEST_clinical_caseMIR	SENT2	-	-
22	UI	ui	NC00SC0	C0439453	calificador	209-211	469_QUEST_clinical_caseMIR	SENT2	-	-
23	/	/	Fh	-	-	211-212	469_QUEST_clinical_caseMIR	SENT2	-	-
24	L	l	NCFS000	-	-	212-213	469_QUEST_clinical_caseMIR	SENT2	-	-
25	)	)	Fpt	-	-	213-214	469_QUEST_clinical_caseMIR	SENT2	-	-
26	,	,	Fc	-	-	214-215	469_QUEST_clinical_caseMIR	SENT2	-	-
27	así	así	RG	-	-	216-219	469_QUEST_clinical_caseMIR	SENT2	-	-
28	como	como	SPS00	C0332257	calificador	220-224	469_QUEST_clinical_caseMIR	SENT2	-	-
29	de	de	SPS00	C0332285	atributo	225-227	469_QUEST_clinical_caseMIR	SENT2	-	-
30	fosfatasa	fosfatasa	NCFS000	C0002059_1	sustancia_1	228-237	469_QUEST_clinical_caseMIR	SENT2	-	-
31	alcalina	alcalino	AQ0FS0	C0002059_2	sustancia_2	238-246	469_QUEST_clinical_caseMIR	SENT2	-	-
32	(	(	Fpa	-	-	247-248	469_QUEST_clinical_caseMIR	SENT2	-	-
33	155	155		-	-	248-251	469_QUEST_clinical_caseMIR	SENT2	-	-
34	UI	ui	NC00SC0	C0439453	calificador	252-254	469_QUEST_clinical_caseMIR	SENT2	-	-
35	/	/	Fh	-	-	254-255	469_QUEST_clinical_caseMIR	SENT2	-	-
36	L	l	NCFS000	-	-	255-256	469_QUEST_clinical_caseMIR	SENT2	-	-
37	)	)	Fpt	-	-	256-257	469_QUEST_clinical_caseMIR	SENT2	-	-
38	y	y	CC	C1706368	calificador	258-259	469_QUEST_clinical_caseMIR	SENT2	-	-
39	gammaglutamil_x0002_transpeptidasa	gammaglutamil_x0002_transpeptidasa		-	-	260-294	469_QUEST_clinical_caseMIR	SENT2	-	-
40	(	(	Fpa	-	-	295-296	469_QUEST_clinical_caseMIR	SENT2	-	-
41	125	125		-	-	296-299	469_QUEST_clinical_caseMIR	SENT2	-	-
42	UI	ui	NC00SC0	C0439453	calificador	300-302	469_QUEST_clinical_caseMIR	SENT2	-	-
43	/	/	Fh	-	-	302-303	469_QUEST_clinical_caseMIR	SENT2	-	-
44	L	l	NCFS000	-	-	303-304	469_QUEST_clinical_caseMIR	SENT2	-	-
45	)	)	Fpt	-	-	304-305	469_QUEST_clinical_caseMIR	SENT2	-	-
46	,	,	Fc	-	-	305-306	469_QUEST_clinical_caseMIR	SENT2	-	-
47	con	con	SPS00	C0332287	atributo	307-310	469_QUEST_clinical_caseMIR	SENT2	-	-
48	una	una		C0205447_1	calificador_1	311-314	469_QUEST_clinical_caseMIR	SENT2	-	-
49	cifra	cifra	NCFS000	-	-	315-320	469_QUEST_clinical_caseMIR	SENT2	-	-
50	de	de	SPS00	C0332285	atributo	321-323	469_QUEST_clinical_caseMIR	SENT2	-	-
51	bilirrubina	bilirrubina	NCFS000	C0201913_1	procedimiento_1	324-335	469_QUEST_clinical_caseMIR	SENT2	-	-
52	total	total	NCMS000	C0201913_2	procedimiento_2	336-341	469_QUEST_clinical_caseMIR	SENT2	-	-
53	de	de	SPS00	C0332285	atributo	342-344	469_QUEST_clinical_caseMIR	SENT2	-	-
54	2,3	2.3	Z	-	-	345-348	469_QUEST_clinical_caseMIR	SENT2	-	-
55	mg	mg	NCMN000	-	-	349-351	469_QUEST_clinical_caseMIR	SENT2	-	-
56	/	/	Fh	-	-	351-352	469_QUEST_clinical_caseMIR	SENT2	-	-
57	dL	decilitro	NCMN000	C0439241	calificador	352-354	469_QUEST_clinical_caseMIR	SENT2	-	-
58	.	.	Fp	-	-	354-355	469_QUEST_clinical_caseMIR	SENT2	-	-

1	El	el	DA0MS0	-	-	356-358	469_QUEST_clinical_caseMIR	SENT3	-	-
2	hemograma	hemograma	NCMS000	C0200631	procedimiento	359-368	469_QUEST_clinical_caseMIR	SENT3	-	-
3	y	y	CC	C1706368	calificador	369-370	469_QUEST_clinical_caseMIR	SENT3	-	-
4	el	el	DA0MS0	-	-	371-373	469_QUEST_clinical_caseMIR	SENT3	-	-
5	estudio	estudio	NCMS000	C0557651	medio_ambiente	374-381	469_QUEST_clinical_caseMIR	SENT3	-	-
6	de	de	SPS00	C0332285	atributo	382-384	469_QUEST_clinical_caseMIR	SENT3	-	-
7	coagulación	coagulación	NCFS000	C0441509	procedimiento	385-396	469_QUEST_clinical_caseMIR	SENT3	-	-
8	son	ser	VSIP3P0	-	-	397-400	469_QUEST_clinical_caseMIR	SENT3	-	-
9	normales	normal	AQ0CP0	C0205307	calificador	401-409	469_QUEST_clinical_caseMIR	SENT3	-	-
10	,	,	Fc	-	-	409-410	469_QUEST_clinical_caseMIR	SENT3	-	-
11	la	el	DA0FS0	-	-	411-413	469_QUEST_clinical_caseMIR	SENT3	-	-
12	ecografía	ecografía	NCFS000	C0041618	calificador#procedimiento	414-423	469_QUEST_clinical_caseMIR	SENT3	-	-
13	abdominal	abdominal	AQ0CS0	C0000726	calificador	424-433	469_QUEST_clinical_caseMIR	SENT3	B-Estructura_Corporal	-
14	no	no	RN	C1298908	calificador	434-436	469_QUEST_clinical_caseMIR	SENT3	-	-
15	muestra	mostrar	VMIP3S0	-	-	437-444	469_QUEST_clinical_caseMIR	SENT3	-	-
16	alteraciones	alteración	NCFP000	-	-	445-457	469_QUEST_clinical_caseMIR	SENT3	B-Grp_Enfermedad	Negacion
17	hepáticas	hepático	AQ0FP0	-	-	458-467	469_QUEST_clinical_caseMIR	SENT3	B-Estructura_Corporal	-
18	ni	ni	CC	-	-	468-470	469_QUEST_clinical_caseMIR	SENT3	-	-
19	biliares	biliar	AQ0CP0	-	-	471-479	469_QUEST_clinical_caseMIR	SENT3	B-Estructura_Corporal	-
20	y	y	CC	C1706368	calificador	480-481	469_QUEST_clinical_caseMIR	SENT3	-	-
21	la	el	DA0FS0	-	-	482-484	469_QUEST_clinical_caseMIR	SENT3	-	-
22	serología	serología	NCFS000	-	-	485-494	469_QUEST_clinical_caseMIR	SENT3	-	-
23	de	de	SPS00	C0332285	atributo	495-497	469_QUEST_clinical_caseMIR	SENT3	-	-
24	virus	virus	NCMN000	C0042776	organismo	498-503	469_QUEST_clinical_caseMIR	SENT3	B-Grp_Enfermedad	Negacion
25	de	de	SPS00	C0332285	atributo	504-506	469_QUEST_clinical_caseMIR	SENT3	I-Grp_Enfermedad	-
26	hepatitis	hepatitis	NCFN000	C0019158	-	507-516	469_QUEST_clinical_caseMIR	SENT3	I-Grp_Enfermedad	Negacion
27	,	,	Fc	-	-	516-517	469_QUEST_clinical_caseMIR	SENT3	-	-
28	así	así	RG	-	-	518-521	469_QUEST_clinical_caseMIR	SENT3	-	-
29	como	como	SPS00	C0332257	calificador	522-526	469_QUEST_clinical_caseMIR	SENT3	-	-
30	los	el	DA0MP0	-	-	527-530	469_QUEST_clinical_caseMIR	SENT3	-	-
31	autoanticuerpos	autoanticuerpo	NCMP000	C0004358	sustancia	531-546	469_QUEST_clinical_caseMIR	SENT3	-	-
32	son	ser	VSIP3P0	-	-	547-550	469_QUEST_clinical_caseMIR	SENT3	-	-
33	negativos	negativo	AQ0MP0	C0205160#C0549184	calificador	551-560	469_QUEST_clinical_caseMIR	SENT3	-	-
34	.	.	Fp	-	-	560-561	469_QUEST_clinical_caseMIR	SENT3	-	-

1	¿	¿	Fia	-	-	562-563	469_QUEST_clinical_caseMIR	SENT4	-	-
2	Cuál	cuál	PT0CS000	-	-	563-567	469_QUEST_clinical_caseMIR	SENT4	-	-
3	de	de	SPS00	C0332285	atributo	568-570	469_QUEST_clinical_caseMIR	SENT4	-	-
4	las	el	DA0FP0	-	-	571-574	469_QUEST_clinical_caseMIR	SENT4	-	-
5	siguientes	siguiente	AQ0CP0	C0332282	atributo	575-585	469_QUEST_clinical_caseMIR	SENT4	-	-
6	actitudes	actitud	NCFP000	C0004271	entidad_observable	586-595	469_QUEST_clinical_caseMIR	SENT4	-	-
7	es	ser	VSIP3S0	-	-	596-598	469_QUEST_clinical_caseMIR	SENT4	-	-
8	la	el	DA0FS0	-	-	599-601	469_QUEST_clinical_caseMIR	SENT4	-	-
9	correcta	correcto	AQ0FS0	C0205170	calificador	602-610	469_QUEST_clinical_caseMIR	SENT4	-	-
10	?	?	Fit	-	-	610-611	469_QUEST_clinical_caseMIR	SENT4	-	-

